Oncothyreon News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.02.18	New Training Simulator Takes Flight with Government Support (PR Newswire)
20.12.17	Organigram Announces Results of 2017 Annual & Special Meeting (PR Newswire)
05.12.17	GB Sciences Announces Tissue Propagation Breakthrough In Commercial Cannabis Cultivation (PR Newswire)
02.11.17	IIROC Trading Resumption - LJ, MCS (PR Newswire)
01.06.15	Pre-market Movers For June 1 (ALTR, INTC, OMG, ONTY, VBLT, FGP) (RTTNews)
15.12.14	CCXI Swells On Trial Data, PETM Taken Private, Genmab Gets Richer, Onus On ONTY (RTTNews)
12.12.14	Oncothyreon Announces Exclusive License Deal With Array BioPharma For ONT-380 (RTTNews)
07.04.14	Oncothyreon : Merck KGaA Initiates Phase 3 START2 Study With Tecemotide (RTTNews)
20.02.14	Oncothyreon, Array BioPharma Announce Initiation Of Phase 1b Trial Of ONT-380 (RTTNews)
03.02.14	Oncothyreon, Array BioPharma Announce Initiation Of Phase 1b Trial Of ONT-380 (RTTNews)
17.10.13	Search Minerals Announces New Strategic Direction (PR Newswire)
11.10.13	Georgetown Capital Corp. Changes name to Auryn Resources Ltd. (PR Newswire)
07.10.13	Oncothyreon Presents Final Results From First Phase 1 Trial Of ONT-380 (RTTNews)
07.10.13	Oncothyreon Announces Presentation of Final Results from Phase 1 Trial of ONT-380 (PR Newswire)
30.09.13	Conference Calls, New Appointments, Agreements, Pricing of Offerings and New Clinical Trials - Research Report on Abbott, Cubist, Pacific Biosciences, Synageva, and Oncothyreon (PR Newswire)
26.09.13	Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo (PR Newswire)
25.09.13	Pre-market Movers For Sept 25 (FB, MAKO, SYK, ONTY, BRCD, ASNA, AZO, LNDC) (RTTNews)
25.09.13	Merck Serono Decides To Continue Development Of Tecemotide In Stage III NSCLC (RTTNews)
25.09.13	Oncothyreon Announces Merck Serono Decision to Continue the Development of Tecemotide in Stage III Non-Small Cell Lung Cancer (PR Newswire)
23.09.13	Sterling Resources provides update regarding Breagh (PR Newswire)
18.09.13	Survey finds dogs and cats try to eat the craziest things (PR Newswire)
06.09.13	Oncothyreon Announces Appointment of Ted W. Love, M.D. to Board of Directors (PR Newswire)
04.09.13	RMTI Awaits CRUISE-2, AVNR On A High, ENTA Gets More Funds, Watch Out For ZLCS (RTTNews)
06.08.13	Oncothyreon to Present at Wedbush Securities Life Sciences Management Access Conference (PR Newswire)
30.07.13	Oncothyreon Announces Second Quarter 2013 Financial Results Conference Call (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	85.10	3.35 %	K V
Novartis	98.15	1.54 %	K V
Roche Hldg G	298.40	1.05 %	K V
Givaudan	3’927.00	1.00 %	K V
Sika	237.80	0.85 %	K V
CieFinRichemont	180.35	0.14 %	K V
Swiss Re	138.30	-0.04 %	K V
Lonza Grp	583.60	-0.10 %	K V
ABB	52.26	-0.19 %	K V
Holcim	94.36	-0.49 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Oncothyreon Inc

Aktien Top/Flop

Meistgelesene Nachrichten